Canada Artificial Organs and Bionics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Canada Artificial Organs and Bionics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Canada Artificial Organs and Bionics Market is expected to register a CAGR of 6.5% over the forecast period (2022-2027).

The COVID-19 pandemic caused by SARS-CoV-2 seriously threatens global public health. All types of elective and semi-urgent medical care and procedures have been discontinued during the pandemic to maintain the capacity to care for patients with this disease. The pandemic has profoundly impacted healthcare and the entire medical community and impacted the studied market significantly. During the initial phase of the pandemic due to the lockdowns and shutdowns, the market was impacted adversely. The number of transplants decreased during the initial phase of the pandemic. However, the adoption of cardiac bionics increased owing to the increasing cases of cardiovascular diseases in Canada. Thus, the initial period of pandemic adversaly impacted the market. However, with opening of world and growing number of transplant due to pending cases are likely to accelerate the market growth durign the forecast period.

The reasons that are driving the artificial organs and bionics market in the region are the rising incidence of organ failures and the scarcity of donor organs. Most patients suffered from mild to moderate symptoms and recover after the initial disease phase, which is dominated by symptoms and signs of viral response like fever, dry cough, and lymphopenia. However, a considerable number of patients developed an increasing host inflammatory response symptom after the initial phase with dyspnoea and hypoxemia up to life-threatening organ impairment like acute respiratory distress syndrome, shock, and cardiac failure. Thus, an increase in organ impairment due to COVID-19 led to an increase in organ transplantation. For instance, in 2021, an article titled, “Lung transplantation for acute COVID-19: the Toronto Lung Transplant Program experience” reported that outcomes show the feasibility and considerations of lung transplantation in patients following severe acute COVID-19 in Toronto.

Also, the scarcity of lungs in the region is fueling the studied market in the region. For another instance, in 2022 Canadian Institute of Health Information reported that a total of 2,782 organ transplants were performed in Canada 2021 about 78% of transplants were performed using deceased donor organs, and 21% used living donor organs. The above source also quoted that for every transplant that occurred in Canada in 2021, approximately 1.5 patients were waiting to receive an organ. For each organ-specific transplant that occurred, 2.3 patients were waiting for a pancreas, 1.8 were waiting for a kidney, 1 was waiting for a heart and less than 1 were waiting for a liver or a lung. The source also quoted that in 2021, a total of 652 Canadians were removed from the organ transplant waitlist. Of these, 38% had died while waiting. As of December 31, 2021, a total of 4,043 Canadians were on wait lists to receive a transplant. 57% were active on the waitlist and 43% were on hold due to a medical or other reason for a short period.

Thus, due to aforesaid mentioned reasons, the market is expected to show significant growth over the forecast period. However, the high cost of the procedure and the risk of compatibility issues and malfunctions may slow down the market growth during the studied period.

Key Market TrendsArtificial Kidney Segment is Expected to Witness a Significant Growth Over the Forecast Years

The artificial kidney segment is expected to have significant growth over the forecast period owing to the rising number of transplant surgeries and the large population suffering from kidney diseases. According to Canadian Institute for Health Information (CIHI), in 2022, report 2021, there were 1,673 kidney transplants and as of December 31, 2021, 3,060 people were waiting for a transplant. There were 105 deaths in 2021 while waiting for a transplant. The kidney transplant offers the best possible improvement to health and quality of life for many people living with kidney failure. However, the need for organ transplantation is much greater than the available supply.

Another reason for the high number of kidney transplants reported in the region is the high cases of chronic kidney diseases. Chronic kidney disease happens when there is kidney damage, or decreased kidney function, for three months or more. Diabetes and high blood pressure are the main causes of chronic kidney disease in Canada. For instance, in 2022, an article titled, “Mortality and Resource Use Among Individuals With Chronic Kidney Disease or Cancer in Alberta, Canada” reported that the most common cause of death was chronic kidney disease (CKD). Thus, the high cases of a kidney disorders are also causing an increasing demand for artificial kidney transplants, thereby driving the market in the region.

Therefore, due to the aforesaid mentioned reasons, the market is expected to show significant growth over the forecast period.

Competitive Landscape

The Canada artificial organs and bionics market is competitive in nature due to the presence of multiple companies operating in Canada. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Asahi Kasei Medical Co, Ltd., Baxter International Inc., Berlin Heart GmbH, Boston Scientific Corporation, Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, and Ossur.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.